CUAMC
VERA icon

China Universal Asset Management Company’s Vera Therapeutics VERA Stock Holding History

China Universal Asset Management Company’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$509K Buy
12,663
+2,246
+22% +$96.8K 0.04% 259
2025
Q4 		$528K Sell
10,417
-770
-7% -$27.3K 0.04% 255
2025
Q3 		$325K Sell
11,187
-1,622
-13% -$37.5K 0.03% 283
2025
Q2 		$302K Buy
12,809
+22
+0.2% +$495 0.03% 280
2025
Q1 		$307K Sell
12,787
-640
-5% -$20.6K 0.03% 284
2024
Q4 		$568K Buy
13,427
+2,882
+27% +$128K 0.05% 239
2024
Q3 		$466K Buy
10,545
+4,118
+64% +$156K 0.05% 228
2024
Q2 		$233K Sell
6,427
-3,690
-36% -$146K 0.03% 217
2024
Q1 		$436K Buy
10,117
+4,974
+97% +$177K 0.06% 195
2023
Q4 		$79.1K Buy
+5,143
New +$65.3K 0.02% 312

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

China Universal Asset Management Company's VERA Position: Q1 2026 in Review

China Universal Asset Management Company increased its Vera Therapeutics (VERA) stake by 22% in Q1 2026, buying an estimated $96.8K and bringing the position to 12,663 shares worth $509K. The position accounts for 0.04% of the portfolio, ranked #259.

China Universal Asset Management Company first reported a position in VERA in Q4 2023 and has held it in 10 quarters since. The position peaked at $568K in Q4 2024. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • China Universal Asset Management Company held 12,663 shares of Vera Therapeutics worth $509K as of Q1 2026.
  • China Universal Asset Management Company bought 2,246 Vera Therapeutics shares in Q1 2026, an estimated $96.8K.
  • Vera Therapeutics made up 0.04% of China Universal Asset Management Company's portfolio in Q1 2026, its #259 holding.
  • China Universal Asset Management Company first reported a position in Vera Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • China Universal Asset Management Company's Vera Therapeutics position peaked at $568K in Q4 2024.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.